Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03585231 · ClinicalTrials.gov registry record · NA
Pilot Trial of the First Conversational Agent for Smoking Cessation (QuitBot)
A NA study, sponsored by Fred Hutchinson Cancer Center.
- Completed
- Registry status
- NA
- Development phase
- 404
- Enrollment target
NCT03585231 is a NA study that has completed, run by Fred Hutchinson Cancer Center. The registered enrollment target is 404 participants.
The verdict
NCT03585231, a NA study, has completed, sponsored by Fred Hutchinson Cancer Center.
- COMPLETED
- Registry status
- NA
- Development phase
- 404 participants
- Enrollment target
Study Summary
Conversational agents (CAs) are computer-powered digital coaches designed to form long-term social-emotional connections with users through conversations. We have developed a CA for cigarette smoking cessation. In a pilot randomized trial (N = 415), we will compare the experimental messaging program (n = 155) with the standard of care national government smoking cessation messaging program (n = 157), and then we will compare immediate (n=51) versus delayed (n=51) access to the the experimental messaging program, to assess 12-week usability, receptivity, and preliminary cessation results in adults in western Washington State and nationally across the US who want to quit smoking.
Interventions
- BEHAVIORAL Immediate access to novel messaging program intervention
- BEHAVIORAL Immediate access to standard of care messaging program intervention
- BEHAVIORAL Delayed access to novel novel messaging program intervention
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 404 participants |
| Start Date | 2018-09-17 |
| Est. Completion | 2020-12-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03585231
The ClinicalTrials.gov registry entry for NCT03585231 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 404 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Fred Hutchinson Cancer Center, which has 483 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Immediate access to novel messaging program intervention is the first listed.
NCT03585231 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03585231 about?
NCT03585231 is a clinical study titled "Pilot Trial of the First Conversational Agent for Smoking Cessation (QuitBot)". Conversational agents (CAs) are computer-powered digital coaches designed to form long-term social-emotional connections with users through conversations. We have developed a CA for cigarette smoking cessation. In a pilot randomized trial (N = 415), we will compare the experimental messaging program...
What is the current status of trial NCT03585231?
This trial is currently completed. It is a NA study. The enrollment target is 404 participants. The study started on 2018-09-17. Estimated completion is 2020-12-02.
What interventions are being tested in trial NCT03585231?
The interventions under investigation include: Immediate access to novel messaging program intervention (BEHAVIORAL), Immediate access to standard of care messaging program intervention (BEHAVIORAL), Delayed access to novel novel messaging program intervention (BEHAVIORAL).
Who is sponsoring clinical trial NCT03585231?
This trial is sponsored by Fred Hutchinson Cancer Center, which has 483 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.